Page last updated: 2024-08-16

ribavirin and Infections, Respiratory Syncytial Virus

ribavirin has been researched along with Infections, Respiratory Syncytial Virus in 262 studies

Research

Studies (262)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	98 (37.40)	18.2507
2000's	76 (29.01)	29.6817
2010's	71 (27.10)	24.3611
2020's	17 (6.49)	2.80

Authors

Authors	Studies
Fang, J; He, B; Hou, D; Huo, X; Liu, FW; Liu, L; Meng, Y; Wang, H; Wang, Z; Wei, Z	1
Alffenaar, JW; de Zwart, A; Glanville, AR; Gottlieb, J; Kerstjens, H; Lunter, G; Permpalung, N; Riezebos-Brilman, A; Verschuuren, E; Vonk, J	1
Muangman, N; Sunhapanit, S; Wongsurakiat, P	1
Gerber, JS; Hersh, AL; Lee, G; Otto, WR; Thurm, CW	1
Karakoc, HN; Manuel, O; Martinez-Reviejo, R; Peña-López, Y; Rello, J; Tejada, S	1
Abdalla, M; Afreen, S; Das Mohapatra, PK; Mitra, D	1
Beaune, S; Benghanem, S; Casalino, E; Celante, H; de Montmollin, E; de Prost, N; Epaillard, N; Fourati, S; Heming, N; Khellaf, M; Layese, R; Mekontso Dessap, A; Oubaya, N; Ricard, JD; Vieillard-Baron, A	1
Alffenaar, JC; de Zwart, AES; Kerstjens, HAM; Riezebos-Brilman, A; Verschuuren, EAM	2
Ison, MG; Nam, HH	1
Alexander, BD; Arif, S; Miller, RA; Permpalung, N; Reynolds, JM; Saullo, JL; Thaniyavarn, T	1
Akhmedov, M; Bunjes, D; Döhner, H; Gantner, A; Kuchenbauer, F; Michel, D; Neagoie, A; Nguyen, TM; Sala, E; Schubert, A; von Harsdorf, S; Wais, V	1
Boyoglu-Barnum, S; Tripp, RA	1
Alffenaar, JC; de Zwart, AES; Gan, CT; Kerstjens, HAM; Riezebos-Brilman, A; van den Heuvel, ER; van der Bij, W; Verschuuren, EAM	1
Antoniadou, A; Baltadakis, I; Chondropoulos, S; Economopoulou, C; Gigantes, S; Gkirkas, K; Goussetis, E; Karagiannidi, A; Karakasis, D; Meletiadis, J; Pournaras, S; Siafakas, N; Stamouli, M; Tsirigotis, P; Tsonis, I	1
Gorczyńska, E; Jarmoliński, T; Kałwak, K; Matkowska-Kocjan, A; Olejnik, I; Rosa, M; Ussowicz, M	1
Dai, YL; Li, KW; Li, Y; Liang, YY; Niu, FJ; Wan, XH; Wang, YY; Wei, HC; Zhou, CZ	1
Libre, C; Oleinikov, A; Rahman, F; Tcherniuk, S	1
Ballester, I; Calabuig, M; Hernández-Boluda, JC; Madrid, S; Marín, M; Navarro, D; Piñana, JL; Solano, C; Terol, MJ; Teruel, A	1
Cerchietti, L; Chadburn, A; Chen, Z; Furman, RR; Leonard, JP; Martin, P; Rutherford, SC; Stewart, EN; van Besien, K; Wehrli, NE	1
He, S; Li, WS; Luo, YJ; Ye, CL; Zhang, ZY	1
Fan, F; He, L; Hou, X; Sun, Y; Wang, J; Wu, H; Xu, H	1
Lee, SH; Yoon, BW	1
Doernberg, SB; Hilts-Horeczko, A; Liu, C; Trang, TP; Whalen, M	1
Bajwa, RPS; Barnum, JL; Gertz, SJ; Kong, M; Moffet, J; Rowan, CM; Zinter, MS	1
Estébanez, M; Membrillo, FJ; Ramírez-Olivencia, G; Ybarra, MDC	1
Azzi, JM; Chemaly, RF; El Haddad, L; Ghantoji, SS; Heredia-Ariza, E; Kyvernitakis, A; Mahajan, SN; Shah, DP	1
Aitken, SL; Ariza-Heredia, E; Chemaly, RF; Foolad, F; Ghantoji, S; Prayag, A; Shigle, TL	1
Bose, ME; Chiu, MC; Chu, H; He, J; Henrickson, KJ; Ho-Yin Wong, B; Hu, M; Huang, JD; Li, C; Luo, YS; Shuai, H; Sun, Z; Wang, D; Wang, Y; Wen, L; Yang, D; Ye, ZW; Yuan, S; Zhang, K; Zhang, X; Zhao, H; Zhao, X; Zheng, B; Zhou, J	1
Li, N; Niu, F; Zhang, C	1
Balassa, K; Barton, D; Benamore, R; Danby, R; Jeffery, K; Lubowiecki, M; Maouche, N; Misbah, SA; Pawson, R; Peniket, A; Rocha, V; Rowley, L; Salisbury, R; Tseu, B; Watson, E	1
Das, A; Ison, MG; Nam, H; Schmidt, H; Yang, A	1
Chemaly, RF; Foolad, F	1
Husain, S; Jain, SR; Phoompoung, P	1
Fätkenheuer, G; Gillor, D; Kochanek, M; Platten, M; Salzberger, B	1
Chemaly, RF; Munsell, MF; Shah, DP	2
Day, CW; Hurst, BL; Januszczyk, P; Krajczyk, A; Kulinska, K; Kulinski, T; Ostrowski, T; Smee, DF; Zeidler, J	1
Champlin, RE; Chemaly, RF; El Taoum, KK; Ghantoji, SS; Hosing, C; Jiang, Y; Popat, U; Rondon, G; Shah, DP; Shah, JN; Tarrand, JJ	1
Ajib, S; Berger, A; Bug, G; Duenzinger, U; Gueller, S; Martin, H; Mousset, S; Serve, H; Wolf, T	1
Chang, JS; Chiang, LC; Lin, CC; Lin, TJ; Wang, KC	1
Pavlisko, EN; Perfect, JR; Rubach, MP	1
Robinson, JL	1
Casey, J; Kennedy, GA; Morris, K; Nakagaki, M; Narayana, M	1
Ariza-Heredia, E; Champlin, RE; Chemaly, RF; El Taoum, KK; Ghantoji, SS; Mulanovich, V; Nunez, CA; Shah, DP; Shah, JN	1
Marcelin, JR; Razonable, RR; Wilson, JW	1
Ariza-Heredia, EJ; Champlin, RE; Chemaly, RF; El Taoum, KK; Ghantoji, SS; Hosing, C; Nesher, L; Rondon, G; Shah, DP; Shah, JN; Shah, PK	1
Cummins, N; Dabo, AJ; Foronjy, RF; Geraghty, P; Taggart, CC; Weldon, S	1
Douglas, T; Melvin, M; Mooney, K	1
Boeckh, MJ; Chemaly, RF; Shah, DP	1
Chi, H; Chiu, NC; Huang, DT; Huang, FY; Lee, YI; Peng, CC	1
Chen, ZG; Dai, QG; Wang, SC; Xu, JY	1
De Clercq, E	1
Benzimra, M; Burrows, FS; Carlos, LM; Glanville, AR; Havryk, AP; Malouf, MA; Marriott, DJ; Plit, ML	1
Domínguez López, SL; Fernández Sierra, MA; Jiménez Romano, E; Molina Rueda, MJ	1
Kim, HJ; Wi, GR; Xu, ML	1
Aljabr, W; Barr, JN; Fearns, R; Hertz-Fowler, C; Hiscox, JA; Hughes, M; Kenny, J; Matthews, DA; Munday, DC; Pollakis, G; Touzelet, O; Wu, W	1
Chin, J; Chu, HY; Englund, JA; Pollard, J; Zerr, DM	1
Alkhateeb, HB; Bartoo, G; Cartin-Ceba, R; Damlaj, M; Gastineau, D; Gijima, D; Hashmi, S; Hogan, W; Litzow, M; Merten, J; Patnaik, MM	1
Alangaden, G; Beaird, OE; Clark, NM; Freifeld, A; Hawkinson, D; Ison, MG; Kaul, DR; Lawrence, SJ; Miller, R; Pursell, K; Razonable, RR; Smith, J; Theodoropoulos, N; Young, JA	1
Dandoy, C; Danziger-Isakov, L; Davies, SM; El-Bietar, J; Jodele, S; Lane, A; Myers, KC; Nelson, A; Teusink, A; Wallace, G	1
Aitken, SL; Boeckh, MJ; Chemaly, RF; Jain, R; Wolfe, CR	1
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH	1
Ariza-Heredia, EJ; Chemaly, RF; Shahani, L	1
Battersby, E; Davies, E; Dignan, FL; Gorcea, CM; Saif, M; Tholouli, E; Turner, A	1
Bode, U; Eis-Huebinger, AM; Panning, M; Schildgen, O; Simon, A	1
Calangu, S; Kalayoglu Beşişik, S; Midilli, K; Ozsüt, H; Sargin, D; Sen, F; Yilmaz, G	1
Force, SD; Foster, M; Gal, AA; Lawrence, EC; Lyon, GM; Mitchell, PO; Naik, PM; Neujahr, DC; Pelaez, A; Ramirez, AM	1
Ai, J; Bai, WJ; Li, RL; Wang, SC; Yang, Y	1
Agrawal, SG; Cavenagh, JD; Gribben, J; Mattes, FM; Oakervee, H; Tsitsikas, DA	1
Cai, SX; Luo, LM; Tong, WC; Xia, H; Yu, HP	1
Weisman, LE	1
Dhillon, GS; Liu, V; Weill, D	1
Avetisyan, G; Ljungman, P; Mattsson, J; Sparrelid, E	1
Agaoglu, L; Anak, S; Atay, D; Devecioglu, O; Garipardic, M; Karakas, Z; Ozturk, G; Unuvar, A	1
Randolph, A; Ventre, K	2
Kuyumjian, AG; McCoy, D; Munk, GB; Sebti, R; Wong, E; Wynd, MA	1
Chemaly, RF; Shah, JN	1
Krilov, LR	2
Li, RL; Wang, SC; Yang, Y	1
Aisa, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Takeshita, K; Yamane, A	1
Huang, CY; Lee, YC; Luo, YH; Yang, KY	1
Bansal, A; Grover, S; Mathew, J; Singhi, SC	1
Hegele, RG	1
Walsh, EE	1
Abbo, L; Ariza-Heredia, EJ; Cleary, T; Fishman, JE; Razonable, RR; Smith, L	1
Falsey, AR; Walsh, EE	1
Deng, Y; He, Y; Li, SM; Liu, EM; Wang, LJ; Xie, XH; Yang, XQ; Zang, N	1
Ensor, CR; Hynicka, LM	1
Florescu, DF; Kalil, AC; Keck, M; Mercer, DF; Mindru, C	1
Avery, R; Budev, M; Danziger-Isakov, L; Li, L; Mossad, S	1
Arslan, D; Benden, C; Danziger-Isakov, LA; Goldfarb, S; Sweet, S; Wong, J	1
Bodey, GP; Champlin, RE; Chemaly, RF; Hosing, C; Munsell, MF; Raad, II; Rathod, DB; Saifan, C; Shah, DP; Torres, HA	1
Gómez-Rosa, M; Molinos-Quintana, A; Pérez-de Soto, C; Pérez-Hurtado, JM; Pérez-Simón, JA	1
Verger, EE; Verger, JT	1
Boeckh, M; Campbell, AP; Chien, JW; Englund, JA; Leisenring, WM; Seo, S; Xie, H	1
Jafri, HS	1
Mejías, A; Ramilo, O	1
Edell, D; Khoshoo, V; Ross, G; Salter, K	1
Field, K; Seymour, JF; Slavin, MA	1
Bertoch, D; Dolan, S; Todd, J	1
Panitch, HB	1
Bojarskas, J; Miseviciene, V	1
Powell, LD; Torrence, PF	1
Yamazaki, T	1
Fergie, J; Purcell, K	3
Anaissie, EJ; Aslan, T; Barlogie, B; Desikan, R; Fassas, A; Mahfouz, TH; Pouli, A	1
Hall, CB	1
Welliver, RC	1
Buxbaum-Conradi, H; Jäger, G; Kolb, HJ; Schleuning, M	1
Shen, KL; Zhao, YH	1
Bowlin, TL; Lukacs, NW; Miller, AL	1
Akers, WS; Flynn, JD; Jahania, S; Jones, M; Mullett, T; Stevkovic, N; Waid, T	1
Boeckh, M; Corey, L; Peck, AJ	1
Bonville, CA; Domachowske, JB; Easton, AJ; Rosenberg, HF	1
Berry, G; Bolger, G; Dansereau, N; Klosowski, K; Lagacé, L; Lapeyre, N; Liuzzi, M; Mewhort, T	1
Gilroy, N; Kerridge, I	1
Selgelid, MJ	1
Annals, G; O'Malley, J	1
Torda, A	1
Gilbert, L	1
Keown, R	1
Cramer, H; Kuang, M; Okicki, JR; Xu, Z	1
Tsutsumi, H	1
Aboyoun, CL; Carter, IW; Glanville, AR; Malouf, MA; Morton, JM; Plit, ML; Scott, AI	1
Lauts, NM	1
Francioli, P; Hirsch, HH; Steffen, I; Widmer, AF	1
Chávez-Bueno, S; Mejías, A; Welliver, RC	1
Boeckh, M; Cross, A; Englund, J; Fernandez, H; Gnann, J; Kim, H; Kuypers, J; Li, Y; Miller, C; Whitley, R	1
Randolph, AG; Ventre, K	1
Falsey, AR	1
Aguilera, EA; Cabanillas, ME; Chemaly, RF; Jiang, Y; Kantarjian, HM; Mattiuzzi, GN; Raad, II; Rohatgi, N; Safdar, A; Sepulveda, CA; Torres, HA	1
Ahmad, N; Chávez-Bueno, S; Jafri, HS; Mejías, A; Merryman, RA; Ramilo, O	1
Decker, M; Fluckiger, U; Gratwohl, A; Halter, J; Heim, D; Hirsch, HH; Khanna, N; Steffen, I; Weisser, M; Widmer, AF	1
Chen, CH; Chiang, BL; Kao, CL; Lee, JH; Lin, YT; Wang, LC; Yang, YH	1
Carré, P; Didier, A; Léophonte, P; Murris-Espin, M	1
Fibbe, WE; Kroes, AC; van Dissel, JT; Zijlmans, JM	1
Davis, C; Firmin, RK; Kerr, SJ; Khan, JY; McCrae, D; Skeoch, C; Sosnowski, A; Tometzki, A; Tyszczuk, L; West, J	1
Atwood, GF; Feldstein, TJ; Peterson, CD; Swegarden, JL	1
Rückert, DG	2
Meadow, WL; Zucker, AR	1
Notterman, DA; Pon, S	1
Arcalà Bares, LI; Pérez Alvarez, F; Titus Boher, J	1
Edmunds, T; Hallam, N	1
Marquardt, ED	1
Joffe, A; Mitchell, I; Newth, CJ	1
Garbarg-Chenon, A; Sardet, A	1
Desager, KS; Van Bever, HP; Van Hoeck, K	1
Ahn, YM; Englund, JA; Gilbert, BE; Hiatt, P; Piedra, PA	1
Moler, FW	1
Wåhlin, B	1
Besunder, JB; Kumar, ML; Pope, JF; Super, DM	1
Nahata, MC; Schad, PA	1
Grøgaard, J; Lindgren, C	1
Shaunak, S; Sriskandan, S	1
Runton, N	1
Dashefsky, B; Wald, ER	1
Holbrook, PR; Krafte-Jacobs, B	1
Gelmini, MJ; Lieh-Lai, MW; Meert, KL; Sarnaik, AP	1
Zucker, AR	1
Turner, RB	1
Levin, MJ	1
Ameratunga, SN; Anderson, B; Asher, MI; Lennon, DR; Spinetto, H	1
Adams, DA	1
Champlin, RE; Englund, JA; Goodrich, JM; Luna, MA; Mirza, NQ; Morice, RC; Neumann, JL; Piedra, PA; Przepiorka, D; Whimbey, E	1
Andreeff, M; Baxter, B; Couch, RB; Englund, JA; Goodrich, JM; Lewis, V; Luna, MA; Mirza, N; Raad, II; Whimbey, E	1
Saarinen, UM; Ukkonen, P; Vettenranta, K	1
Hertz, MI; Wendt, CH	1
Bar-Yosef, G; Ben-Porath, E; Bentur, L; Brik, R; Efrath, M; Ischah-Adiv, A	1
Hayden, FG	1
De Boeck, K; Moens, M; Schuddinck, L	1
Gross, TJ; Hunninghake, GW; Mastronarde, JG; Monick, MM	1
Moler, FW; Ohmit, SE; Steinhart, CM; Stidham, GL	1
Khan, AS; Moler, FW; Monto, AS; Ohmit, SE	1
Hubert, P	1
Randolph, AG; Wang, EE	2
Boucher, FD; Dobson, S; Langley, JM; Law, BJ; MacDonald, NE; McDonald, J; Mitchell, I; Robinson, JL; Stephens, D; Wang, EE	1
De Vincenzo, JP; Leombruno, D; Siber, GR; Soiffer, RJ	1
Steele, RW	1
Boucher, FD; de Carvalho, V; Dobson, S; Langley, JM; Law, BJ; MacDonald, NE; McDonald, J; Mitchell, I; Robinson, JL; Stephens, D; Wang, EE	1
Bozzette, M	1
Hellström, LG; Malmström, B; Soop, M; Wåhlin, B	1
Granger, CD	1
Demers, RR	1
Bowden, RA; Crawford, SW; Lewinsohn, DM; Mattson, D	1
Zamorski, M	1
Nicod, LP	1
Prober, CG; Wang, EE	1
Falsey, AR; Mlinaric-Galinovic, G; Walsh, EE	1
Barone, SR; Fagin, JC; Krilov, LR; Mandel, FS	1
Boucher, F; Dobson, S; Langley, J; Law, BJ; MacDonald, N; McDonald, J; Mitchell, I; Robinson, J; Stephens, D; Wang, EE	1
Kimpen, JL; Schaad, UB	1
Andersson, J; Aschan, J; Ekelöf-Andström, E; Ljungman, P; Ringdén, O; Sparrelid, E; Wåhlin, B; Winiarski, J	1
Allport, TD; Davies, EG; Sharland, M; Wells, C	1
Abi-Said, D; Bodey, G; Champlin, R; Englund, J; Garcia, R; Hill, LA; Neumann, J; Raad, I; Tarrand, J; Umphrey, J; Whimbey, E	1
Castillo-Ochando, F; Díaz-Torres, M; Pajarón de Ahumada, M; Sánchez-Flores, F; Sánchez-Solís de Querol, M; Sayed-Sancho, N	1
Barker, WH; Hall, CB; Long, CE; Voter, KZ	1
Graber, MA; Levy, BT	1
Hemming, VG; Ottolini, MG	1
Adlakha, A; Markovic, SN; Smith, TF; Walker, RC	1
Darville, T; Yamauchi, T	1
Bremner, J; Chopra, R; Corser, RB; McColl, MD	1
Basgoz, N; Flieder, DB; Ginns, LC; Kradin, R; Krinzman, S; Shepard, JA; Wain, JC; Wright, CD	1
Margo, KL; Shaughnessy, AF	1
Mora Pascual, A	1
DeVincenzo, J	2
McBride, JT; McConnochie, KM	1
Bruce, E; Edell, D; Hale, K; Khoshoo, V	1
Clauvel, JP; Eftekhari, P; Lassoued, K; Oksenhendler, E; Scieux, C	1
Cheseaux, JJ; Cotting, J; Guignard, JP; Ventura, F	2
Hall, CB; McCarthy, CA	1
Choy, G	1
Aujard, Y	1
Arrobio, J; Fink, R; Kim, HW; Milburn, C; Rodriguez, WJ	1
Dominguez, KD; Mercier, RC	1
Coss-Bu, JA; Englund, JA; Jefferson, LS; Stein, F; Walding, D	1
Rodriguez, WJ	1
Konno, K; Mori, S; Shigeta, S; Sudo, K; Watanabe, W; Yokota, T	1
Dimond, J	1
Luyt, DK; Nichani, S; Oommen, A	1
Farrell, CA; Gauthier, M; Guerguerian, AM; Lacroix, J; Lebel, MH	1
Anaissie, E; Aslan, T; Barlogie, B; Desikan, R; Fassas, AB; Mehta, J; Munshi, N; Siegel, D; Singhal, S	1
Adams, R; Beatty, P; Christenson, J; Petersen, F	1
Mills, J	1
Bibes, B; Briens, E; Dauriac, C; Grosbois, B; Jego, P; Minjolle, S	1
Baker, KA; Ryan, ME	1
Caul, EO; Cornish, JM; Foot, AB; Grier, D; Kelly, C; Kingman, HM; Marks, DI; McCarthy, AJ; Moppett, J; Oakhill, A; Pamphilon, DH; Steward, CG; Taylor, GS	1
DeVincenzo, JP; Fuentes, RJ; Hirsch, RL; Top, FH	1
Linehan, JM	1
Champlin, RE; Englund, J; Ghosh, S; Giralt, SA; Ippoliti, C; Jacobson, K; Mallik, S; Neumann, J; Raad, I; Rolston, K; Whimbey, E	1
Moscona, A	1
Kimpen, J; van Woensel, J	1
de Groot, R; Kneyber, MC; Moll, HA	1
Edell, D; Khoshoo, V	1
Kimura, K; Mori, S; Ohno, K; Shigeta, S; Takahashi, K; Terada, M; Tomita, K	1
Ghosh, S; Whimbey, E	1
DeVincenzo, JP	1
Heilmann, CJ; Hornsleth, AK; Pedersen, BK; Thorsen, S	1
Shigeta, S	1
Brand, PL; Kimpen, JL; Van Woensel, JB	1
Anderson, B; Bakri, FG; Ball, D; Bernstein, SH; Bernstein, ZP; Brown, K; Czuczman, MS; Keesler, C; Khushalani, NI; McCarthy , PL; Mohr, A; Segal, BH; Wentling, D	1
Anderlini, P; Champlin, RE; Ghosh, S; Jacobson, K; Kontoyiannis, D; Luna, M; Raad, I; Rolston, K; Tarrand, J; Ueno, NT; Whimbey, E	1
López Jiménez, J; Pérez De Oteyza, J; Pintado, V; Quereda, C	1
Boeckh, M; Gooley, T; Nichols, WG	1
Adams, RH	1
Chakrabarti, S; Collingham, KE; Fegan, CD; Holder, K; Milligan, DW; Osman, H	1
Bye, MR; Ngai, P	1
Staat, MA	1
Boulad, F; Casson, A; Kiehn, TE; Malak, SF; Sepkowitz, KA; Small, TN; Stiles, J; Ushay, HM	1
Greenough, A	1
Carmack, MA; Prober, CG	1

Reviews

75 review(s) available for ribavirin and Infections, Respiratory Syncytial Virus

Article	Year
Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 07-06, Volume: 74, Issue:12 Topics: Humans; Lung; Metapneumovirus; Parainfluenza Virus 1, Human; Parainfluenza Virus 2, Human; Paramyxoviridae Infections; Prospective Studies; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Transplant Recipients	2022
Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis. Advances in therapy, 2022, Volume: 39, Issue:9 Topics: Adult; Antiviral Agents; Child; Humans; Respiratory Aerosols and Droplets; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin	2022
Respiratory syncytial virus infection in adults. BMJ (Clinical research ed.), 2019, 09-10, Volume: 366 Topics: Adult; Antiviral Agents; Epidemics; Genotype; Global Burden of Disease; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin; Seasons	2019
Up-to-date role of biologics in the management of respiratory syncytial virus. Expert opinion on biological therapy, 2020, Volume: 20, Issue:9 Topics: Antiviral Agents; Biological Products; Child; Humans; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Ribavirin; Viral Fusion Proteins	2020
Qingkailing Injection () for Treatment of Children Pneumonia Induced by Respiratory Syncytial Virus: A Meta-Analysis of Randomized Controlled Trials. Chinese journal of integrative medicine, 2018, Volume: 24, Issue:4 Topics: Cough; Drugs, Chinese Herbal; Fever; Humans; Injections; Pneumonia; Publication Bias; Randomized Controlled Trials as Topic; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	2018
Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:2 Topics: Antiviral Agents; Drug Administration Routes; Humans; Lung Transplantation; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin	2018
Use of ribavirin in viruses other than hepatitis C. A review of the evidence. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019, Volume: 37, Issue:9 Topics: Adenoviridae Infections; Adenoviruses, Human; Antiviral Agents; Arenaviruses, New World; Clinical Trials as Topic; Coronavirus Infections; Hantavirus Infections; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Crimean; Humans; Lassa Fever; Lassa virus; Meta-Analysis as Topic; Middle East Respiratory Syndrome Coronavirus; Orthohantavirus; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Virus Diseases; Viruses	2019
Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Nov-15, Volume: 59 Suppl 5 Topics: Antiviral Agents; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Influenza, Human; Paramyxoviridae Infections; Pneumonia, Viral; Recombinant Fusion Proteins; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Virus Diseases	2014
Chemotherapy of respiratory syncytial virus infections: the final breakthrough. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Administration, Inhalation; Antiviral Agents; Humans; Indazoles; Pyrazoles; Respiratory Syncytial Virus Infections; Ribavirin; Sulfonamides; Treatment Outcome	2015
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. European journal of cancer (Oxford, England : 1990), 2016, Volume: 67 Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases	2016
Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:4 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir	2017
Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future. Cardiovascular & hematological agents in medicinal chemistry, 2009, Volume: 7, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Humans; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2009
WITHDRAWN: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. The Cochrane database of systematic reviews, 2010, May-12, Issue:5 Topics: Antiviral Agents; Humans; Infant; Infant, Newborn; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	2010
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood, 2011, Mar-10, Volume: 117, Issue:10 Topics: Adult; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Clinical Trials as Topic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin	2011
Respiratory syncytial virus disease: update on treatment and prevention. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:1 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Child; Clinical Trials as Topic; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Treatment Outcome	2011
Respiratory syncytial virus infection in adults. Seminars in respiratory and critical care medicine, 2011, Volume: 32, Issue:4 Topics: Adult; Antibodies, Monoclonal, Humanized; Antiviral Agents; Humans; Immunocompromised Host; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin; United States	2011
Respiratory syncytial virus infection in adult populations. Infectious disorders drug targets, 2012, Volume: 12, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Humans; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Viral Load; Young Adult	2012
Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunologic Factors; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	2012
Respiratory syncytial virus bronchiolitis in children. Critical care nursing clinics of North America, 2012, Volume: 24, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchiolitis; Child; Child, Preschool; Continuous Positive Airway Pressure; Female; Humans; Infant; Male; Nutrition Therapy; Palivizumab; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	2012
Role of chemokines in respiratory syncytial virus disease. The Pediatric infectious disease journal, 2002, Volume: 21, Issue:5 Topics: Antiviral Agents; Chemokines; Child; Humans; Models, Biological; Respiratory Syncytial Virus Infections; Ribavirin; Steroids	2002
Safety issues related to the administration of ribavirin. The Pediatric infectious disease journal, 2002, Volume: 21, Issue:5 Topics: Abnormalities, Drug-Induced; Absorption; Administration, Inhalation; Adult; Antiviral Agents; Child; Child, Preschool; Female; Health Personnel; Humans; Infant; Infant, Newborn; Inhalation Exposure; Occupational Exposure; Pregnancy; Respiratory Protective Devices; Respiratory Syncytial Virus Infections; Ribavirin; Risk Assessment; Teratogens	2002
Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:2 Suppl Topics: Airway Obstruction; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Child; Child, Preschool; Disease Progression; Fluid Therapy; Humans; Infant; Infant, Newborn; Oxygen Inhalation Therapy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Risk Factors; Severity of Illness Index; Virus Replication	2003
[Current treatment options for acute bronchiolitis in children]. Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:3 Topics: Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Child, Preschool; Clinical Trials as Topic; Epinephrine; Female; Humans; Infant; Male; Oxygen Inhalation Therapy; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	2003
The quest for an efficacious antiviral for respiratory syncytial virus. Antiviral chemistry & chemotherapy, 2002, Volume: 13, Issue:6 Topics: 2',5'-Oligoadenylate Synthetase; Adenine Nucleotides; Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Drug Design; Endoribonucleases; Humans; Infant; Interferons; Membrane Fusion; Mice; Middle Aged; Molecular Structure; Oligodeoxyribonucleotides, Antisense; Oligoribonucleotides; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; RNA, Viral; Viral Proteins	2002
[Bronchiolitis (RS virus infection)]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Administration, Inhalation; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Viral; Antiviral Agents; Bronchiolitis, Viral; Diagnosis, Differential; Humans; Injections, Intramuscular; Palivizumab; Prognosis; Reagent Kits, Diagnostic; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	2003
Respiratory syncytial virus infection: therapy and prevention. Paediatric respiratory reviews, 2004, Volume: 5 Suppl A Topics: Antiviral Agents; Bronchiolitis; Bronchodilator Agents; Child; Humans; Immunization, Passive; Respiratory Syncytial Virus Infections; Ribavirin; Vaccination; Viral Fusion Proteins; Viral Vaccines	2004
[Advances in pharmacotherapy of respiratory syncytial virus and rhinovirus infections]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2004, Volume: 42, Issue:2 Topics: Antiviral Agents; Child; Deoxyribonuclease (Pyrimidine Dimer); Humans; Immunization, Passive; Infant; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Ribavirin	2004
Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature. Pharmacotherapy, 2004, Volume: 24, Issue:7 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Humans; Lung Transplantation; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Viral Vaccines	2004
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4 Topics: Antiviral Agents; Humans; Infant; Infant, Newborn; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	2004
The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacology & therapeutics, 2005, Volume: 105, Issue:1 Topics: Animals; Antiviral Agents; Humans; Mice; Murine pneumonia virus; Pneumovirus Infections; Respiratory Syncytial Virus Infections; Ribavirin	2005
[Respiratory syncytial virus]. Uirusu, 2005, Volume: 55, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Clinical Trials as Topic; Drug Design; Humans; Infant; Infant, Newborn; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Viral Fusion Proteins	2005
RSV: protecting the littlest patients. RN, 2005, Volume: 68, Issue:12 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child, Preschool; Disease Outbreaks; Hospitalization; Humans; Infant; Infant, Newborn; Infection Control; Nurse's Role; Palivizumab; Pediatric Nursing; Primary Prevention; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors; Seasons; United States; Viral Vaccines	2005
[Respiratory syncytial virus infections: measures in immunocompromised patients]. Praxis, 2006, Jan-18, Volume: 95, Issue:3 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Drug Therapy, Combination; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors; Stem Cell Transplantation; Time Factors	2006
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1 Topics: Antiviral Agents; Humans; Infant; Infant, Newborn; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	2007
Respiratory syncytial virus infection in adults. Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Antiviral Agents; Asthma; Communicable Disease Control; Communicable Diseases; Cross Infection; Homes for the Aged; Humans; Middle Aged; Nursing Homes; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Ribavirin	2007
[Treatment of respiratory syncytial virus infections--a review. Part 1]. Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege, 1995, Volume: 14, Issue:2 Topics: Humans; Respiratory Syncytial Virus Infections; Ribavirin; Therapeutic Irrigation	1995
Ribavirin in severe respiratory syncytial virus infection. Critical care medicine, 1994, Volume: 22, Issue:4 Topics: Humans; Respiratory Syncytial Virus Infections; Ribavirin	1994
Treatment and prevention options for respiratory syncytial virus infections. The Journal of pediatrics, 1994, Volume: 124, Issue:5 Pt 2 Topics: Child; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Viral Vaccines	1994
Ribavirin therapy of respiratory syncytial virus infections. The New Zealand medical journal, 1994, May-11, Volume: 107, Issue:977 Topics: Aerosols; Child; Humans; Respiratory Syncytial Virus Infections; Ribavirin	1994
Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics, 1996, Volume: 97, Issue:1 Topics: Antiviral Agents; Bias; Clinical Trials as Topic; Humans; Research Design; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	1996
Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Seminars in respiratory infections, 1995, Volume: 10, Issue:4 Topics: Antiviral Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Paramyxoviridae Infections; Respiratory Syncytial Virus Infections; Ribavirin	1995
Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. Archives of pediatrics & adolescent medicine, 1996, Volume: 150, Issue:9 Topics: Antiviral Agents; Humans; Infant; Infant, Newborn; Length of Stay; Oxygen Inhalation Therapy; Research Design; Respiration, Artificial; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Treatment Outcome	1996
Respiratory syncytial virus infection in infants: a significant challenge for optimal care. The Journal of perinatal & neonatal nursing, 1996, Volume: 10, Issue:2 Topics: Antiviral Agents; Humans; Infant; Infant, Newborn; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	1996
[Infectious complications of lung and heart-lung transplantation]. Revue des maladies respiratoires, 1996, Volume: 13, Issue:5 Suppl Topics: Acyclovir; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Bacterial Infections; Chemoprevention; Cytomegalovirus Infections; Ganciclovir; Graft Survival; Heart-Lung Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Lung Transplantation; Lymphoproliferative Disorders; Mycobacterium Infections, Nontuberculous; Nocardia Infections; Pneumonia, Pneumocystis; Respiratory Syncytial Virus Infections; Ribavirin; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Tumor Virus Infections; Virus Diseases	1996
Respiratory syncytial virus infection in the elderly. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:10 Topics: Aged; Antiviral Agents; Disease Transmission, Infectious; Humans; Recurrence; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Vaccination	1996
Respiratory syncytial virus infection in infants and young children. The Journal of family practice, 1997, Volume: 45, Issue:6 Topics: Anti-Inflammatory Agents; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Hospitalization; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1997
Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery. Drugs, 1997, Volume: 54, Issue:6 Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antiviral Agents; Humans; Immunoglobulins, Intravenous; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	1997
Respiratory syncytial virus pneumonitis-induced diffuse alveolar damage in an autologous bone marrow transplant recipient. Mayo Clinic proceedings, 1998, Volume: 73, Issue:2 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Female; Hodgkin Disease; Humans; Immunoglobulins, Intravenous; Pneumonia; Pulmonary Alveoli; Respiratory Syncytial Virus Infections; Ribavirin; Transplantation, Autologous	1998
Respiratory syncytial virus. Pediatrics in review, 1998, Volume: 19, Issue:2 Topics: Antiviral Agents; Child; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1998
Antiviral drugs in healthy children. American family physician, 1998, Mar-01, Volume: 57, Issue:5 Topics: Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Child; Child, Preschool; Drug Administration Schedule; Herpes Simplex; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Rimantadine; Virus Diseases	1998
Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases). Advances in pediatric infectious diseases, 1997, Volume: 13 Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Bronchopulmonary Dysplasia; Cost-Benefit Analysis; Disease Models, Animal; Heart Defects, Congenital; Humans; Immunization, Passive; Immunocompromised Host; Infant; Infant, Newborn; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vaccination	1997
Recent approaches to the management and prevention of respiratory syncytial virus infection. Current clinical topics in infectious diseases, 1998, Volume: 18 Topics: Antiviral Agents; Humans; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Viral Vaccines	1998
A review of respiratory syncytial virus infection in infants and children. Home care provider, 1998, Volume: 3, Issue:6 Topics: Antiviral Agents; Child, Preschool; Hospitalization; Humans; Immunoglobulins, Intravenous; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1998
[Respiratory syncytial virus infections and ribavirin: the controversy continues]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:2 Topics: Antiviral Agents; Costs and Cost Analysis; France; Humans; Respiratory Syncytial Virus Infections; Ribavirin	1998
Treatment of RSV pneumonia in adults--evidence of ribavirin effectiveness? The Annals of pharmacotherapy, 1999, Volume: 33, Issue:6 Topics: Adult; Antiviral Agents; Clinical Trials as Topic; Humans; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin	1999
Management strategies for respiratory syncytial virus infections in infants. The Journal of pediatrics, 1999, Volume: 135, Issue:2 Pt 2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Clinical Trials as Topic; Humans; Immunization, Passive; Infant; Infant, Newborn; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin	1999
Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone marrow transplantation, 1999, Volume: 24, Issue:5 Topics: Aged; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Incidence; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Pilot Projects; Respiratory Syncytial Virus Infections; Ribavirin; Transplantation Conditioning	1999
Prevention and treatment of respiratory syncytial virus infections. Advances in experimental medicine and biology, 1999, Volume: 458 Topics: Animals; Antiviral Agents; Humans; Immunization; Immunotherapy; Respiratory Syncytial Virus Infections; Ribavirin	1999
RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention? Postgraduate medicine, 1999, Volume: 106, Issue:7 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchodilator Agents; Child, Preschool; Fluid Therapy; Hospitalization; Humans; Immunization, Passive; Infant; Palivizumab; Primary Prevention; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors; Steroids	1999
Respiratory syncytial virus: understanding the threat to communities. Journal of the American Academy of Nurse Practitioners, 1999, Volume: 11, Issue:8 Topics: Antiviral Agents; Humans; Infection Control; Nurse Practitioners; Public Health; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	1999
Management of respiratory syncytial virus infections in the immunocompromised child. The Pediatric infectious disease journal, 2000, Volume: 19, Issue:3 Topics: Antiviral Agents; Child; Humans; Immunocompromised Host; Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Risk Factors; Viral Vaccines	2000
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiviral Agents; Humans; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	2000
Therapy for respiratory tract infections caused by respiratory syncytial virus. European journal of pediatrics, 2000, Volume: 159, Issue:6 Topics: Adrenal Cortex Hormones; Antiviral Agents; Bronchodilator Agents; Child; Humans; Immunization, Passive; Meta-Analysis as Topic; Respiratory Syncytial Virus Infections; Ribavirin	2000
Treatment and prevention of respiratory syncytial virus infection. European journal of pediatrics, 2000, Volume: 159, Issue:6 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; Bronchodilator Agents; Child; Humans; Immunization, Passive; Immunoglobulins, Intravenous; Infant; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Vaccines, Synthetic; Viral Vaccines	2000
Respiratory syncytial virus infections in immunocompromised adults. Current clinical topics in infectious diseases, 2000, Volume: 20 Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Diagnosis, Differential; Humans; Immunization, Passive; Immunocompromised Host; Leukemia; Pneumonia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Steroids; Virion	2000
Therapy of respiratory syncytial virus infection. The Pediatric infectious disease journal, 2000, Volume: 19, Issue:8 Topics: Antiviral Agents; Child; Child, Preschool; Controlled Clinical Trials as Topic; Female; Humans; Immunocompromised Host; Infant; Male; Prognosis; Respiratory Syncytial Virus Infections; Ribavirin; Risk Assessment; Survival Rate; Viral Load	2000
[Treatment of respiratory syncytial virus infections in immunocompromised hematological patients]. Ugeskrift for laeger, 2000, Aug-28, Volume: 162, Issue:35 Topics: Aerosols; Aged; Antiviral Agents; Bone Marrow Transplantation; Humans; Immunocompromised Host; Infant; Leukopenia; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors	2000
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2 Topics: Amides; Animals; Antibodies, Monoclonal; Antiviral Agents; Biopolymers; Bridged-Ring Compounds; Catechin; Drugs, Investigational; Heterocyclic Compounds; Humans; Immunoglobulins, Intravenous; Lipids; N-Acetylneuraminic Acid; Norbornanes; Oligodeoxyribonucleotides, Antisense; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Ribonucleosides; Ribose; Risk Factors; Thiocarbamates; Thiones	2000
Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment. Minerva pediatrica, 2001, Volume: 53, Issue:2 Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Child, Preschool; Clinical Trials as Topic; Diagnosis, Differential; Humans; Immunoglobulins; Infant; Infant, Newborn; Meta-Analysis as Topic; Respiratory Syncytial Virus Infections; Ribavirin	2001
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review. Bone marrow transplantation, 2001, Volume: 27, Issue:10 Topics: Adult; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Immunoglobulins, Intravenous; Male; Respiratory Syncytial Virus Infections; Ribavirin; Time Factors; Transplantation, Homologous	2001
Management of infections caused by respiratory syncytial virus. Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	2001
Bronchiolitis. Pediatric annals, 2002, Volume: 31, Issue:2 Topics: Antiviral Agents; Bronchiolitis; Bronchodilator Agents; Humans; Immunization; Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2002
Respiratory syncytial virus infections in children. Seminars in respiratory infections, 2002, Volume: 17, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchodilator Agents; Child; Disease Outbreaks; Global Health; Humans; Immunization, Passive; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Risk Factors; Seasons; United States	2002
Respiratory syncytial virus infection: clinical features, management, and prophylaxis. Current opinion in pulmonary medicine, 2002, Volume: 8, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Asthma; Child; Child, Preschool; Cross Infection; Glucocorticoids; Hospitalization; Humans; Immunoglobulins, Intravenous; Immunotherapy; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infection Control; Palivizumab; Pulmonary Surfactants; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin	2002
Respiratory syncytial virus and ribavirin: quo vadis? Infectious agents and disease, 1992, Volume: 1, Issue:2 Topics: Animals; Clinical Trials as Topic; Humans; Respiratory Syncytial Virus Infections; Ribavirin	1992

Trials

23 trial(s) available for ribavirin and Infections, Respiratory Syncytial Virus

Article	Year
Evaluation by survival analysis on effect of traditional Chinese medicine in treating children with respiratory syncytial viral pneumonia of phlegm-heat blocking Fei syndrome. Chinese journal of integrative medicine, 2009, Volume: 15, Issue:2 Topics: Airway Obstruction; Child, Preschool; Drugs, Chinese Herbal; Female; Fever; Hot Temperature; Humans; Infant; Male; Medicine, Chinese Traditional; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory System; Ribavirin; Single-Blind Method; Survival Analysis; Syndrome; Treatment Outcome	2009
[Effect of Qingkailing Injection on children with respiratory syncytial virus pneumonia of phlegm-heat obstructing Fei syndrome pattern at different time-points]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2010, Volume: 30, Issue:9 Topics: Child; Diagnosis, Differential; Drugs, Chinese Herbal; Female; Guaiacol; Humans; Infusions, Intravenous; Male; Medicine, Chinese Traditional; Phytotherapy; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin	2010
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. The Journal of infectious diseases, 2012, Volume: 206, Issue:9 Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Antiviral Agents; Female; Humans; Male; Middle Aged; Neoplasms; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Treatment Outcome; Young Adult	2012
Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity. Chest, 2002, Volume: 122, Issue:3 Topics: Bronchiolitis, Viral; Female; Follow-Up Studies; Humans; Infant; Length of Stay; Male; Prospective Studies; Respiratory Syncytial Virus Infections; Ribavirin; Survival Rate	2002
Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:12 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2005
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jan-15, Volume: 44, Issue:2 Topics: Adolescent; Adult; Aerosols; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Viral Load	2007
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2008, Volume: 19, Issue:2 Topics: Antiviral Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypersensitivity; Infant; Lung Diseases; Male; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Risk Factors; Taiwan; Time	2008
High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. The Journal of pediatrics, 1994, Volume: 125, Issue:4 Topics: Aerosols; Air Microbiology; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Oxygen Inhalation Therapy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Treatment Outcome	1994
Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Critical care medicine, 1994, Volume: 22, Issue:4 Topics: Aerosols; Double-Blind Method; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Prospective Studies; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin	1994
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone marrow transplantation, 1995, Volume: 16, Issue:3 Topics: Administration, Inhalation; Adult; Antiviral Agents; Bone Marrow Transplantation; Cross Infection; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Survival Analysis	1995
Study of interobserver reliability in clinical assessment of RSV lower respiratory illness: a Pediatric Investigators Collaborative Network for Infections in Canada (PICNIC) study. Pediatric pulmonology, 1996, Volume: 22, Issue:1 Topics: Antiviral Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Observer Variation; Prognosis; Reproducibility of Results; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1996
Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Humans; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin	1996
Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Pediatrics, 1997, Volume: 99, Issue:3 Topics: Antiviral Agents; Bronchiolitis; Community-Acquired Infections; Hospitalization; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Length of Stay; Prospective Studies; Regression Analysis; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Severity of Illness Index	1997
Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infection control and hospital epidemiology, 1997, Volume: 18, Issue:6 Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Hand Disinfection; Humans; Incidence; Infection Control; Inservice Training; Patient Isolation; Protective Devices; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Texas; Visitors to Patients	1997
Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. The Pediatric infectious disease journal, 1997, Volume: 16, Issue:11 Topics: Antiviral Agents; Child; Child, Preschool; Female; Follow-Up Studies; Growth; Hospitalization; Humans; Male; Recurrence; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1997
[Is the use of ribavirin aerosols in respiratory syncytial virus infections justified? Clinical and economic evaluation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:2 Topics: Aerosols; Albuterol; Antiviral Agents; Cohort Studies; Costs and Cost Analysis; Female; France; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Respiratory Syncytial Virus Infections; Respiratory Therapy; Ribavirin; Risk Factors	1998
Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group. Archives of pediatrics & adolescent medicine, 1999, Volume: 153, Issue:5 Topics: Antiviral Agents; Bronchiolitis; Bronchoconstrictor Agents; Follow-Up Studies; Humans; Infant; Longitudinal Studies; Methacholine Chloride; Prospective Studies; Respiratory Function Tests; Respiratory Sounds; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	1999
Respiratory system mechanics in patients receiving aerosolized ribavirin during mechanical ventilation for suspected respiratory syncytial viral infection. Pediatric pulmonology, 1999, Volume: 28, Issue:2 Topics: Administration, Inhalation; Aerosols; Airway Resistance; Antiviral Agents; Bronchiolitis, Viral; Child, Preschool; Humans; Infant; Lung Compliance; Prospective Studies; Respiration, Artificial; Respiratory Mechanics; Respiratory Syncytial Virus Infections; Ribavirin	1999
Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. American journal of respiratory and critical care medicine, 1999, Volume: 160, Issue:3 Topics: Administration, Inhalation; Aerosols; Analysis of Variance; Antiviral Agents; Bronchiolitis; Chi-Square Distribution; Double-Blind Method; Female; Humans; Infant; Male; Prospective Studies; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	1999
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone marrow transplantation, 1999, Volume: 24, Issue:12 Topics: Adolescent; Adult; Child; Child, Preschool; Genotype; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Radiography, Thoracic; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Homologous; Treatment Outcome	1999
Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone marrow transplantation, 2000, Volume: 25, Issue:2 Topics: Administration, Inhalation; Adult; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infant; Neutralization Tests; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Survival Rate; Viral Load	2000
Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone marrow transplantation, 2000, Volume: 25, Issue:7 Topics: Adult; Aerosols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Pilot Projects; Pneumonia, Viral; Postoperative Complications; Respiratory Syncytial Virus Infections; Ribavirin; Transfusion Reaction; Transplantation, Autologous; Transplantation, Homologous	2000
Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2001, Volume: 7 Suppl Topics: Administration, Inhalation; Antibodies, Viral; Bone Marrow Transplantation; Child; Clinical Protocols; Humans; Incidence; Nasal Lavage Fluid; Pilot Projects; Randomized Controlled Trials as Topic; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2001

Other Studies

164 other study(ies) available for ribavirin and Infections, Respiratory Syncytial Virus

Article	Year
Design, synthesis, in vitro and in vivo anti-respiratory syncytial virus (RSV) activity of novel oxizine fused benzimidazole derivatives. European journal of medicinal chemistry, 2021, Nov-15, Volume: 224 Topics: Animals; Antiviral Agents; Apoptosis; Benzimidazoles; Cell Line; Cytokines; Drug Design; Humans; Isomerism; Lung; Mice; Molecular Conformation; Reactive Oxygen Species; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Structure-Activity Relationship; Toll-Like Receptor 3; Virus Replication	2021
Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment. Influenza and other respiratory viruses, 2022, Volume: 16, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiviral Agents; Communicable Diseases; Humans; Immunocompromised Host; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin	2022
Ribavirin Use in Hospitalized Children. Journal of the Pediatric Infectious Diseases Society, 2022, 08-30, Volume: 11, Issue:8 Topics: Antiviral Agents; Child; Child, Hospitalized; Drug Therapy, Combination; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2022
Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative. Journal of molecular modeling, 2023, Mar-08, Volume: 29, Issue:4 Topics: Antiviral Agents; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Respiratory Syncytial Virus Infections; Ribavirin	2023
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hospitalization; Humans; Male; Prognosis; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin	2023
Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 05-06, Volume: 70, Issue:10 Topics: Aged; Humans; Influenza, Human; Morbidity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2020
Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients. Transplantation, 2020, Volume: 104, Issue:6 Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Antiviral Agents; Female; Forced Expiratory Volume; Humans; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Oxygen; Postoperative Complications; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; RNA, Viral; Transplant Recipients; Treatment Outcome	2020
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:4 Topics: Adult; Aged; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Paramyxoviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Transplantation, Homologous; Treatment Outcome; Viral Load; Young Adult	2020
Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:12 Topics: Antiviral Agents; Humans; Lung; Lung Transplantation; Metapneumovirus; Prospective Studies; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Transplant Recipients	2020
Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation. Bone marrow transplantation, 2021, Volume: 56, Issue:2 Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Paramyxoviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin	2021
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report. Pediatric transplantation, 2021, Volume: 25, Issue:5 Topics: Anemia, Aplastic; Bone Marrow; Child; COVID-19; COVID-19 Drug Treatment; Female; Hematopoietic Stem Cell Transplantation; Humans; Metapneumovirus; Pneumonia, Viral; Postoperative Period; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; SARS-CoV-2; Transplantation, Homologous	2021
Salvia plebeia R. Br. polysaccharides (SPP) against RSV (respiratory syncytial virus) infection: Antiviral effect and mechanisms of action. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141 Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Cytokines; Eating; Humans; Lung; Mice; Mice, Inbred BALB C; Plant Extracts; Polysaccharides; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Salvia; Tetrazolium Salts; Thiazoles; Toll-Like Receptors	2021
Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A. The Journal of general virology, 2021, Volume: 102, Issue:8 Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chloroquine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Mice; Mice, Inbred BALB C; Pyrimethamine; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Virus Replication	2021
A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:4 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Paramyxoviridae Infections; Pilot Projects; Prospective Studies; Respiratory Syncytial Virus Infections; Ribavirin; Stem Cell Transplantation	2017
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data^. Leukemia & lymphoma, 2018, Volume: 59, Issue:1 Topics: Antiviral Agents; Eukaryotic Initiation Factor-4E; Humans; Lymphoma; Remission Induction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin	2018
4(3H)-Quinazolone regulates innate immune signaling upon respiratory syncytial virus infection by moderately inhibiting the RIG-1 pathway in RAW264.7 cell. International immunopharmacology, 2017, Volume: 52 Topics: Animals; Antiviral Agents; Immunity, Innate; Interferon-beta; Isatis; Macrophages; Medicine, Chinese Traditional; Membrane Proteins; Mice; Nerve Tissue Proteins; Oxazolidinones; Plant Roots; Quinazolines; Quinazolinones; RAW 264.7 Cells; Receptors, Cell Surface; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Signal Transduction	2017
Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report. Journal of medical case reports, 2017, Dec-20, Volume: 11, Issue:1 Topics: Administration, Oral; Aged, 80 and over; Antiviral Agents; Humans; Immunocompetence; Male; Real-Time Polymerase Chain Reaction; Respiratory Distress Syndrome; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Treatment Outcome	2017
A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Hospitalized; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Intensive Care Units, Pediatric; Male; Palivizumab; Respiration, Artificial; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Risk Factors; United States	2018
Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hematologic Neoplasms; Humans; Leukopenia; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome; Young Adult	2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 05-02, Volume: 68, Issue:10 Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Medical Records; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin; Risk Factors; Transplant Recipients; Treatment Outcome; Young Adult	2019
Establishment of a lethal aged mouse model of human respiratory syncytial virus infection. Antiviral research, 2019, Volume: 161 Topics: Aging; Animals; Antiviral Agents; Cell Line; Cyclophosphamide; Disease Models, Animal; Genome, Viral; Humans; Lung; Mice; Mice, Inbred BALB C; Mutation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Virus Replication	2019
Baicalein triazole prevents respiratory tract infection by RSV through suppression of oxidative damage. Microbial pathogenesis, 2019, Volume: 131 Topics: Animals; Cytokines; Female; Flavanones; Interferon-beta; Interleukin-6; Interleukin-8; Lymphocytes; Mice; Mice, Inbred BALB C; Neutrophils; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pneumonia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin; STAT3 Transcription Factor; Triazoles; Tumor Necrosis Factor-alpha; Virus Replication	2019
Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation. The Journal of infection, 2019, Volume: 78, Issue:6 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Cohort Studies; Disease Management; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Middle Aged; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Risk Factors; Transplantation, Homologous; Treatment Outcome; Young Adult	2019
Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: A 6-year retrospective study. Influenza and other respiratory viruses, 2019, Volume: 13, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Hospitalization; Humans; Immunocompromised Host; Inpatients; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin; Young Adult	2019
Reply to Jain et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-27, Volume: 69, Issue:12 Topics: Hematopoietic Stem Cell Transplantation; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Transplant Recipients	2019
Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-27, Volume: 69, Issue:12 Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2019
Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 03-03, Volume: 70, Issue:6 Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Transplant Recipients	2020
Aerosolized ribavirin for patients with cancer and respiratory syncytial virus infection. The Journal of infectious diseases, 2013, May-15, Volume: 207, Issue:10 Topics: Aerosols; Antiviral Agents; Female; Humans; Male; Neoplasms; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin	2013
Reply to Fätkenheuer et al. The Journal of infectious diseases, 2013, May-15, Volume: 207, Issue:10 Topics: Aerosols; Antiviral Agents; Female; Humans; Male; Neoplasms; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin	2013
Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling. Antiviral chemistry & chemotherapy, 2014, Jan-29, Volume: 23, Issue:4 Topics: Animals; Antiviral Agents; Cell Line; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Measles; Measles virus; Models, Molecular; Nucleosides; Orthomyxoviridae Infections; Parainfluenza Virus 3, Human; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin; Triazoles	2014
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8 Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Antiviral Agents; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin; Stem Cell Transplantation; Survival Analysis; Texas; Transplantation; Treatment Outcome; Young Adult	2013
Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4 Topics: Adult; Aged; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pharynx; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Transplantation, Homologous; Treatment Outcome	2013
Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell lines. The American journal of Chinese medicine, 2013, Volume: 41, Issue:3 Topics: Antiviral Agents; Cell Line, Tumor; Cytokines; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-beta; Paeonia; Phytotherapy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory System; Ribavirin; Tumor Necrosis Factor-alpha; Virus Attachment; Virus Internalization	2013
Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4 Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Multiple Myeloma; Pericardial Effusion; Pericarditis; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2013
Ribavirin for upper respiratory tract infections. The Journal of infectious diseases, 2013, Sep-01, Volume: 208, Issue:5 Topics: Aerosols; Antiviral Agents; Female; Humans; Male; Neoplasms; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin	2013
Reply to Robinson. The Journal of infectious diseases, 2013, Sep-01, Volume: 208, Issue:5 Topics: Aerosols; Antiviral Agents; Female; Humans; Male; Neoplasms; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin	2013
Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation. Bone marrow transplantation, 2013, Volume: 48, Issue:12 Topics: Administration, Oral; Adult; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Parainfluenza Virus 3, Human; Prognosis; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2013
Respiratory syncytial virus infections in children with cancer. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:6 Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome	2014
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Male; Middle Aged; Radiography; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Severity of Illness Index; Treatment Outcome; Young Adult	2014
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood, 2014, May-22, Volume: 123, Issue:21 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Incidence; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Ribavirin; Treatment Outcome; Young Adult	2014
Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors. Mucosal immunology, 2015, Volume: 8, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Cathepsins; DEAD Box Protein 58; DEAD-box RNA Helicases; Gene Expression Regulation, Viral; Interferon Type I; Leucine; Lung; Matrix Metalloproteinases; Mice; Mice, Inbred Strains; Mice, Knockout; Phenylalanine; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Thiophenes; Viral Load	2015
Ribavirin: the need for exposure precautions. Clinical journal of oncology nursing, 2014, Volume: 18, Issue:5 Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Nursing Staff; Occupational Health; Respiratory Syncytial Virus Infections; Ribavirin	2014
Risk factors associated with death in patients with severe respiratory syncytial virus infection. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:5 Topics: Antiviral Agents; Child; Child, Preschool; Comorbidity; Cross Infection; Down Syndrome; Female; Hospitalization; Humans; Infant; Intensive Care Units, Pediatric; Male; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Risk Factors; Taiwan; Tertiary Care Centers	2016
[Regulation of Jinxin Oral Liquid for the expression of negative regulatory factor of TLR3 signaling pathway SOCS1 in RSV infected BALB/c mice]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2014, Volume: 34, Issue:12 Topics: Animals; Drugs, Chinese Herbal; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; RNA, Messenger; Signal Transduction; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Toll-Like Receptor 3	2014
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2015, Volume: 34, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Female; Follow-Up Studies; Humans; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult	2015
[Approach to a respiratory syncytial virus outbreak related to medical care in hematology]. Enfermedades infecciosas y microbiologia clinica, 2015, Volume: 33, Issue:8 Topics: Adult; Antiviral Agents; Bronchial Spasm; Cross Infection; Disease Outbreaks; Disease Susceptibility; Female; Hand Hygiene; Hematologic Neoplasms; Hematology; Hospital Departments; Hospitals, University; Humans; Infection Control; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin	2015
The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse. Journal of microbiology (Seoul, Korea), 2015, Volume: 53, Issue:9 Topics: Animals; Antibodies, Viral; Cattle; CD8-Positive T-Lymphocytes; Colostrum; Diet; Disease Models, Animal; Female; Humans; Lung; Mice, Inbred BALB C; Pregnancy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Viral Load	2015
Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach. Journal of virology, 2016, 05-15, Volume: 90, Issue:10 Topics: Antiviral Agents; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Interferon-beta; Mutation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; RNA, Viral; Transcriptome; Viral Plaque Assay; Virus Attachment; Virus Internalization; Virus Replication	2016
Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children. Influenza and other respiratory viruses, 2016, Volume: 10, Issue:3 Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant; Infant, Newborn; Male; Outpatients; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; Risk Factors; Transplantation; Treatment Outcome; United States; Young Adult	2016
Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:2 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Young Adult	2016
Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:2 Topics: Administration, Oral; Antiviral Agents; Data Collection; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Organ Transplantation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Therapy; Ribavirin	2016
RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation. Bone marrow transplantation, 2016, Volume: 51, Issue:10 Topics: Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infant; Male; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Risk Factors; Transplantation, Homologous; Young Adult	2016
Aerosolized ribavirin: the most expensive drug for pneumonia. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:4 Topics: Administration, Inhalation; Adult; Aerosols; Antiviral Agents; Child; Drug Costs; Drug Industry; Drugs, Generic; Economics, Hospital; Health Policy; Hematopoietic Stem Cell Transplantation; Humans; Infant; Orphan Drug Production; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2016
Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients. The Journal of hospital infection, 2017, Volume: 95, Issue:2 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Analysis; Transplant Recipients; Transplantation, Homologous; Treatment Outcome; Young Adult	2017
Respiratory syncytial virus infection in patients with cancer: still more questions than answers. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jun-15, Volume: 46, Issue:12 Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Infant; Male; Neoplasms; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	2008
[Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit]. Mikrobiyoloji bulteni, 2008, Volume: 42, Issue:2 Topics: Antiviral Agents; Cross Infection; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Nasopharynx; Respiratory Syncytial Virus Infections; Ribavirin; Treatment Outcome	2008
Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:1 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Infusions, Intravenous; Lung Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Sarcoidosis; Time Factors	2009
Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience. British journal of haematology, 2009, Volume: 146, Issue:5 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin	2009
[Effect of ribavirin upon secretion of thymic stromal lymphopoietin in respiratory syncytial virus-induced asthma exacerbation of mice]. Zhonghua yi xue za zhi, 2009, May-26, Volume: 89, Issue:20 Topics: Animals; Antiviral Agents; Asthma; Cytokines; Female; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Thymic Stromal Lymphopoietin	2009
A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Clinical Protocols; Drug Therapy, Combination; Female; Forced Expiratory Volume; Heart-Lung Transplantation; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lung Transplantation; Male; Middle Aged; Palivizumab; Paramyxoviridae Infections; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin; Treatment Outcome	2010
Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Transplantation, 2009, Nov-27, Volume: 88, Issue:10 Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Antiviral Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome	2009
Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT. Pediatric pulmonology, 2010, Volume: 45, Issue:3 Topics: Antiviral Agents; Bone Marrow Transplantation; Child, Preschool; Cross Infection; Disease Outbreaks; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Male; Neoplasms; Respiratory Syncytial Virus Infections; Ribavirin; Turkey	2010
Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline. Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Palivizumab; Respiratory Syncytial Virus Infections; Ribavirin	2011
Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. International journal of hematology, 2011, Volume: 93, Issue:1 Topics: Antiviral Agents; Bronchiolitis Obliterans; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Transplantation, Homologous	2011
Inhaled ribavirin therapy in adult respiratory syncytial virus-induced acute respiratory distress syndrome. Archivos de bronconeumologia, 2011, Volume: 47, Issue:6 Topics: Administration, Inhalation; Adult; Antiviral Agents; Female; Humans; Respiratory Distress Syndrome; Respiratory Syncytial Virus Infections; Ribavirin	2011
Approach to a child with lower airway obstruction and bronchiolitis. Indian journal of pediatrics, 2011, Volume: 78, Issue:11 Topics: Airway Obstruction; Algorithms; Antiviral Agents; Bronchiolitis; Child, Preschool; Clinical Protocols; Diagnosis, Differential; Fluid Therapy; Humans; India; Infant; Oxygen Inhalation Therapy; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory System Agents; Ribavirin	2011
Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner? The European respiratory journal, 2011, Volume: 38, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Benzimidazoles; Humans; Immunoglobulins, Intravenous; Palivizumab; Pyridines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Ribavirin; Viral Fusion Proteins	2011
Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Florida; Hospitalization; Humans; Male; Middle Aged; Organ Transplantation; Radiography; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Young Adult	2012
Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation, 2012, Volume: 35, Issue:4 Topics: Adaptor Proteins, Vesicular Transport; Antiviral Agents; Cell Line; Dexamethasone; Down-Regulation; Epithelial Cells; Humans; Interleukin-6; Interleukin-8; Protein Serine-Threonine Kinases; Respiratory Mucosa; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory System; Resveratrol; Ribavirin; Stilbenes; Virus Replication	2012
Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin. Pediatric transplantation, 2012, Volume: 16, Issue:8 Topics: Administration, Oral; Aerosols; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child, Preschool; Humans; Liver Transplantation; Male; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	2012
Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:8 Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Female; Humans; Lung Transplantation; Male; Middle Aged; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult	2012
RSV prevention and treatment in pediatric lung transplant patients: a survey of current practices among the International Pediatric Lung Transplant Collaborative. Pediatric transplantation, 2012, Volume: 16, Issue:6 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Humans; Infant; International Cooperation; Lung Diseases; Lung Transplantation; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Surveys and Questionnaires; Time Factors; Treatment Outcome	2012
Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients. Bone marrow transplantation, 2013, Volume: 48, Issue:2 Topics: Administration, Intravenous; Antiviral Agents; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Infant; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin	2013
Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:4 Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Longitudinal Studies; Male; Middle Aged; Oxygen Consumption; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Survival Analysis; Transplantation, Homologous; Treatment Outcome	2013
[Asthma and respiratory syncytial virus. Myth or reality?]. Anales espanoles de pediatria, 2002, Volume: 57, Issue:3 Topics: Antiviral Agents; Asthma; Cytokines; Humans; Respiratory Syncytial Virus Infections; Ribavirin	2002
Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. European journal of haematology, 2002, Volume: 69, Issue:1 Topics: Antineoplastic Agents; Antiviral Agents; Cyclophosphamide; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin; Vidarabine	2002
Use of a large national database for comparative evaluation of the effect of a bronchiolitis/viral pneumonia clinical care guideline on patient outcome and resource utilization. Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:11 Topics: Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Databases as Topic; Drug Utilization; Evidence-Based Medicine; Guideline Adherence; Humans; Intensive Care Units; Outcome and Process Assessment, Health Care; Physical Therapy Modalities; Pneumonia, Viral; Practice Guidelines as Topic; Prospective Studies; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin	2002
Effect of an educational program on the treatment of RSV lower-respiratory-tract infection. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Apr-15, Volume: 60, Issue:8 Topics: Antiviral Agents; Cost Savings; Drug Utilization Review; Education, Medical; Female; Health Services Misuse; Hospitals, Pediatric; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Male; Outcome Assessment, Health Care; Practice Patterns, Physicians'; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; United States	2003
The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood, 2004, Mar-01, Volume: 103, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Body Fluids; Female; Humans; Immunoglobulins, Intravenous; L-Lactate Dehydrogenase; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Renal Insufficiency; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Time Factors	2004
Managing bronchiolitis and respiratory syncytial virus: finding the yellow brick road. Archives of pediatrics & adolescent medicine, 2004, Volume: 158, Issue:2 Topics: Antiviral Agents; Bronchiolitis; Child; Child, Preschool; Diagnosis, Differential; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	2004
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:2 Topics: Adenoviridae; Adenovirus Infections, Human; Adolescent; Adult; Aged; Antiviral Agents; Cidofovir; Cytosine; Female; Gastrointestinal Tract; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory System; Ribavirin; Treatment Outcome	2004
Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. The Journal of infectious diseases, 2004, Apr-15, Volume: 189, Issue:8 Topics: Animals; Antiviral Agents; Chemokines; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Lipids; Lung; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; N-Acetylneuraminic Acid; Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; RNA, Viral; Up-Regulation; Virion; Virus Replication	2004
Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. The Pediatric infectious disease journal, 2004, Volume: 23, Issue:5 Topics: Antiviral Agents; Databases, Factual; Hospitalization; Humans; Infant; Infant, Newborn; Infant, Premature; Intensive Care Units; Length of Stay; Medical Records; Pediatrics; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections; Ribavirin; Risk Factors; Severity of Illness Index; Ventilators, Mechanical	2004
Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-01, Volume: 39, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Preoperative Care; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Outcome	2004
Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lung; Mice; Mice, Inbred BALB C; Palivizumab; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Viral Proteins; Virus Replication	2005
In that case. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Bone Marrow Transplantation; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Patient Compliance; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
In that case: response. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
In that case: response. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
In that case: response. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
In that case: response. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
In that case: response. Journal of bioethical inquiry, 2005, Volume: 2, Issue:1 Topics: Adult; Ethics, Institutional; Ethics, Nursing; Female; Hospitals; Humans; Nursing Staff, Hospital; Occupational Exposure; Pregnancy; Pregnancy Complications; Refusal to Treat; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Teratogens	2005
Targeted therapy of respiratory syncytial virus by 2-5A antisense. Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7 Topics: Animals; Chlorocebus aethiops; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Endoribonucleases; Genome, Viral; Humans; Interferons; Mice; Oligonucleotides, Antisense; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; RNA; RNA, Viral; Species Specificity	2005
Respiratory syncytial virus bronchiolitis : current and future strategies for treatment and prophylaxis. Treatments in respiratory medicine, 2006, Volume: 5, Issue:6 Topics: Bronchiolitis; Humans; Infant; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Treatment Outcome; Vaccines, Attenuated; Vaccines, Subunit	2006
Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica, 2007, Volume: 92, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Female; Humans; Infant; Leukemia; Male; Middle Aged; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Survival Rate; Time Factors	2007
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:12 Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hospitals, Pediatric; Humans; Immunocompromised Host; Infant; Infant, Newborn; Injections, Intravenous; Male; Palivizumab; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Severity of Illness Index; Treatment Outcome	2007
Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Feb-01, Volume: 46, Issue:3 Topics: Adult; Cell Culture Techniques; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin	2008
[Respiratory syncytial virus infection in adults]. Revue des maladies respiratoires, 1995, Volume: 12, Issue:4 Topics: Adult; Age Factors; Aged; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Infant; Infant, Newborn; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	1995
Respiratory syncytial virus, a rare cause of severe pneumonia following bone marrow transplantation. Annals of hematology, 1995, Volume: 71, Issue:5 Topics: Adult; Bone Marrow Transplantation; Humans; Lung Diseases, Interstitial; Male; Pneumonia, Viral; Radiography; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Seminoma; Testicular Neoplasms	1995
Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Archives of disease in childhood. Fetal and neonatal edition, 1995, Volume: 73, Issue:2 Topics: Age of Onset; Bronchiolitis, Viral; Bronchopulmonary Dysplasia; Extracorporeal Membrane Oxygenation; Humans; Infant; Infant, Newborn; Infant, Premature; Respiration, Artificial; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Ribavirin; Treatment Outcome	1995
Ribavirin therapy: implementation of hospital guidelines and effect on usage and cost of therapy. Pediatrics, 1995, Volume: 96, Issue:1 Pt 1 Topics: Drug Costs; Drug Utilization Review; Humans; Infant; Infant, Newborn; Pediatrics; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Ribavirin; Societies, Medical; United States	1995
[Treatment of respiratory syncytial virus infections--treatment suggestions according to data from the literature. 2]. Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege, 1995, Volume: 14, Issue:3 Topics: Humans; Respiratory Syncytial Virus Infections; Respiratory Therapy; Ribavirin	1995
Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia. Critical care medicine, 1995, Volume: 23, Issue:4 Topics: Attitude of Health Personnel; Child; Critical Care; Humans; Pediatrics; Pneumonia, Viral; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Ribavirin	1995
Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease. Critical care medicine, 1995, Volume: 23, Issue:4 Topics: Aerosols; Humans; Infant; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1995
Water intoxication after nebulised tribavirin. Lancet (London, England), 1995, Apr-29, Volume: 345, Issue:8957 Topics: Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Nebulizers and Vaporizers; Respiratory Syncytial Virus Infections; Ribavirin; Water Intoxication	1995
Bronchiolitis. Tribavirin may be helpful. BMJ (Clinical research ed.), 1995, Apr-22, Volume: 310, Issue:6986 Topics: Bronchiolitis, Viral; Humans; Infant; Infant, Newborn; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Ribavirin	1995
Cost of ribavirin therapy for respiratory syncytial virus infection. The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 1 Topics: Child; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Time Factors	1995
Ribavirin. Red Book Committee recommendations questioned. Pediatrics, 1995, Volume: 95, Issue:2 Topics: Child; Child, Preschool; Humans; Respiratory Syncytial Virus Infections; Ribavirin	1995
[Respiratory syncytial virus infection in children]. Revue de pneumologie clinique, 1994, Volume: 50, Issue:2 Topics: Child; Child, Preschool; Humans; Infant; Primary Prevention; Respiratory Syncytial Virus Infections; Ribavirin	1994
Water intoxication after nebulised tribavirin. Lancet (London, England), 1995, Feb-18, Volume: 345, Issue:8947 Topics: Bronchiolitis, Viral; Female; Humans; Infant; Nebulizers and Vaporizers; Respiratory Syncytial Virus Infections; Ribavirin; Water Intoxication	1995
Aerosolized ribavirin in mechanically ventilated children. Critical care medicine, 1994, Volume: 22, Issue:12 Topics: Aerosols; Humans; Infant; Respiration, Artificial; Respiratory Insufficiency; Respiratory Syncytial Virus Infections; Ribavirin	1994
[A summary from a Nordic working meeting. Ribavirin therapy of RSV-infected children]. Lakartidningen, 1994, Sep-21, Volume: 91, Issue:38 Topics: Aerosols; Child; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Scandinavian and Nordic Countries	1994
Concerned about ribavirin recommendations. Pediatrics, 1994, Volume: 94, Issue:1 Topics: Child, Preschool; Humans; Infant; Practice Guidelines as Topic; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin	1994
Pattern of drug usage in bronchiolitis. Journal of clinical pharmacy and therapeutics, 1994, Volume: 19, Issue:2 Topics: Albuterol; Aminophylline; Bronchiolitis, Viral; Drug Utilization; Female; Glucocorticoids; Humans; Infant; Infant, Newborn; Male; Respiratory Syncytial Virus Infections; Ribavirin	1994
[Ribavirin treatment of children with respiratory syncytial virus bronchiolitis]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1994, Jun-30, Volume: 114, Issue:17 Topics: Administration, Inhalation; Bronchiolitis, Viral; Female; Humans; Infant, Newborn; Respiratory Syncytial Virus Infections; Ribavirin	1994
Respiratory syncytial virus infection in an adult with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Female; Humans; Middle Aged; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin	1993
Ribavirin. Neonatal network : NN, 1993, Volume: 12, Issue:8 Topics: Administration, Inhalation; Humans; Infant, Newborn; Respiratory Syncytial Virus Infections; Ribavirin	1993
Ribavirin. Red Book Committee recommendations questioned. Pediatrics, 1994, Volume: 93, Issue:4 Topics: Humans; Infant; Pediatrics; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Societies, Medical	1994
Pediatrics academy updates guidelines on ribavirin use. American Academy of Pediatrics. American journal of hospital pharmacy, 1994, Jan-01, Volume: 51, Issue:1 Topics: Child; Guidelines as Topic; Humans; Pediatrics; Respiratory Syncytial Virus Infections; Ribavirin; Societies, Medical; United States	1994
Red Book recommendations on ribavirin challenged. Pediatrics, 1994, Volume: 93, Issue:5 Topics: Humans; Infant; Pediatrics; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Ribavirin; Societies, Medical; United States	1994
Red Book recommendations on ribavirin challenged. Pediatrics, 1994, Volume: 93, Issue:5 Topics: Humans; Infant; Pediatrics; Practice Guidelines as Topic; Respiratory Syncytial Virus Infections; Ribavirin; Societies, Medical; United States	1994
Ribavirin administration via scavenger vacuum systems in the treatment of respiratory syncytial virus (RSV). Journal of pediatric nursing, 1994, Volume: 9, Issue:1 Topics: Administration, Inhalation; Environment, Controlled; Health Personnel; Humans; Infant; Occupational Exposure; Respiratory Syncytial Virus Infections; Ribavirin	1994
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:2 Topics: Acute Disease; Adult; Antigens, Viral; Antineoplastic Agents; Antiviral Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Hospitalization; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Leukemia; Nasopharynx; Pharynx; Pneumonia, Viral; Prospective Studies; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	1995
RSV infection complicating the therapy of pediatric malignancies: report of six cases. Medical and pediatric oncology, 1996, Volume: 26, Issue:4 Topics: Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Ribavirin	1996
[An epidemic of respiratory syncytial virus bronchiolitis among infants in northern Israel]. Harefuah, 1996, Feb-01, Volume: 130, Issue:3 Topics: Adrenal Cortex Hormones; Antiviral Agents; Bronchiolitis, Viral; Disease Outbreaks; Hospitalization; Humans; Infant; Infant, Newborn; Israel; Respiration, Artificial; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin	1996
Combination antiviral therapy for respiratory virus infections. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Amantadine; Animals; Antiviral Agents; Common Cold; Drug Therapy, Combination; Humans; Influenza, Human; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Rimantadine	1996
Early ribavirin treatment did not prevent severe disease in high-risk bronchopulmonary dysplasia patients with respiratory syncytial virus infection. Pediatric pulmonology, 1996, Volume: 21, Issue:5 Topics: Antiviral Agents; Bronchopulmonary Dysplasia; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Respiratory Syncytial Virus Infections; Ribavirin; Risk Factors; Treatment Failure	1996
Amiloride inhibits cytokine production in epithelium infected with respiratory syncytial virus. The American journal of physiology, 1996, Volume: 271, Issue:2 Pt 1 Topics: Amiloride; Antiviral Agents; Cytokines; Epithelium; Glucosephosphate Dehydrogenase; Humans; Pulmonary Alveoli; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; RNA, Messenger; Tumor Cells, Cultured; Virus Replication	1996
Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. The Journal of pediatrics, 1996, Volume: 128, Issue:3 Topics: Administration, Inhalation; Aerosols; Antiviral Agents; Case-Control Studies; Cohort Studies; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Multivariate Analysis; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Severity of Illness Index; Treatment Outcome	1996
Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection. Journal of clinical epidemiology, 1996, Volume: 49, Issue:9 Topics: Antiviral Agents; Drug Utilization; Female; Hospitalization; Humans; Infant; Length of Stay; Male; Multivariate Analysis; Practice Patterns, Physicians'; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Treatment Outcome	1996
[Ribavirin and mechanical ventilation]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1996, Volume: 3, Issue:2 Topics: Antiviral Agents; Child; Humans; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin	1996
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. The Journal of pediatrics, 1996, Volume: 129, Issue:3 Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bronchodilator Agents; Canada; Hospitalization; Hospitals, Pediatric; Humans; Immunocompromised Host; Infant; Infant, Newborn; Intensive Care Units; Length of Stay; Prospective Studies; Respiration, Artificial; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1996
Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. Bone marrow transplantation, 1996, Volume: 17, Issue:6 Topics: Adult; Bone Marrow Transplantation; Female; Humans; Immunization, Passive; Male; Middle Aged; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Ribavirin; Transplantation, Homologous	1996
Reassessment of indications for ribavirin therapy in respiratory syncytial virus infection. Clinical pediatrics, 1996, Volume: 35, Issue:7 Topics: Antiviral Agents; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1996
A paediatric canopy system for aerosol administration and minimized environmental pollution. Acta anaesthesiologica Scandinavica, 1996, Volume: 40, Issue:8 Pt 1 Topics: Administration, Inhalation; Aerosols; Air Pollution, Indoor; Equipment and Supplies, Hospital; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1996
The ribavirin debate. Pediatrics, 1996, Volume: 98, Issue:5 Topics: Clinical Trials as Topic; Humans; Infant; Respiratory Syncytial Virus Infections; Ribavirin	1996
The ribavirin debate. Pediatrics, 1996, Volume: 98, Issue:5 Topics: Clinical Trials as Topic; Humans; Respiratory Syncytial Virus Infections; Ribavirin	1996
Ribavirin for RSV lower respiratory tract infection. The Journal of family practice, 1996, Volume: 43, Issue:6 Topics: Aerosols; Antiviral Agents; Humans; Infant; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Reproducibility of Results; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Risk; Treatment Outcome	1996
Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer. Pediatrics, 1997, Volume: 99, Issue:3 Topics: Antiviral Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Infant; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1997
Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. The Pediatric infectious disease journal, 1997, Volume: 16, Issue:3 Topics: Antiviral Agents; Bronchiolitis; Female; Follow-Up Studies; Hospitalization; Humans; Infant; Male; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Ribavirin	1997
Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. The Pediatric infectious disease journal, 1997, Volume: 16, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Communicable Diseases; Humans; Infant; Policy Making; Population Surveillance; Program Evaluation; Respiratory Syncytial Virus Infections; Ribavirin; Surveys and Questionnaires	1997
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone marrow transplantation, 1997, Volume: 19, Issue:9 Topics: Administration, Oral; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Influenza B virus; Influenza, Human; Injections, Intravenous; Male; Middle Aged; Parainfluenza Virus 1, Human; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation, Autologous; Transplantation, Homologous	1997
Ribavirin and bronchiolitis: variation in use in the UK. Archives of disease in childhood, 1997, Volume: 76, Issue:4 Topics: Antiviral Agents; Bronchiolitis, Viral; Humans; Practice Patterns, Physicians'; Respiratory Syncytial Virus Infections; Ribavirin; United Kingdom	1997
[Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus]. Anales espanoles de pediatria, 1997, Volume: 47, Issue:1 Topics: Acute Disease; Antiviral Agents; Bronchiolitis; Female; Humans; Infant; Infant, Newborn; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin	1997
Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone marrow transplantation, 1998, Volume: 21, Issue:4 Topics: Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Child; Cross Infection; Disease Outbreaks; Female; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Nebulizers and Vaporizers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin	1998
Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:2 Topics: Adult; Antiviral Agents; Female; Heart Transplantation; Humans; Kidney Transplantation; Lung Diseases; Lung Transplantation; Male; Middle Aged; Organ Transplantation; Radiography; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Treatment Outcome	1998
[Ribavirin administration by aerosol]. Revista de enfermeria (Barcelona, Spain), 1998, Volume: 21, Issue:233 Topics: Administration, Inhalation; Aerosols; Antiviral Agents; Child; Drug Monitoring; Humans; Nebulizers and Vaporizers; Respiratory Syncytial Virus Infections; Ribavirin	1998
RSV, recurrent wheezing, and ribavirin. Pediatric pulmonology, 1998, Volume: 25, Issue:3 Topics: Antiviral Agents; Asthma; Bronchial Hyperreactivity; Bronchiolitis; Humans; Infant; Recurrence; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	1998
Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report. Pediatric pulmonology, 1998, Volume: 25, Issue:3 Topics: Albuterol; Antiviral Agents; Asthma; Bronchial Hyperreactivity; Bronchiolitis; Bronchodilator Agents; Follow-Up Studies; Glucocorticoids; Hospitalization; Humans; Infant; Infant, Newborn; Methylprednisolone; Oxygen Inhalation Therapy; Prednisone; Prevalence; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Retrospective Studies; Ribavirin	1998
Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia. Annals of hematology, 1998, Volume: 76, Issue:5 Topics: Administration, Inhalation; Adult; Antineoplastic Agents; Antiviral Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vidarabine	1998
[Syncytial respiratory virus infections and ribavirin]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:7 Topics: Antiviral Agents; Humans; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	1998
Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo. Antiviral chemistry & chemotherapy, 1999, Volume: 10, Issue:3 Topics: Animals; Antiviral Agents; Cyclophosphamide; Disease Models, Animal; Female; HeLa Cells; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Mice; Mice, Inbred BALB C; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin	1999
Another complication of ribavirin therapy in a mechanically ventilated neonate. Paediatric anaesthesia, 1999, Volume: 9, Issue:5 Topics: Aerosols; Antiviral Agents; Crystallization; Equipment Failure; Humans; Infant, Newborn; Male; Respiration, Artificial; Respiratory Insufficiency; Respiratory Syncytial Virus Infections; Ribavirin	1999
Intravenous ribavirin for infant bronchiolitis. Journal of the Royal Society of Medicine, 1999, Volume: 92, Issue:2 Topics: Antiviral Agents; Bronchiolitis, Viral; Humans; Infant; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	1999
Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone marrow transplantation, 1999, Volume: 24, Issue:6 Topics: Adolescent; Adult; Aerosols; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Female; Humans; Infant; Male; Pilot Projects; Respiratory Syncytial Virus Infections; Ribavirin	1999
[Respiratory syncytial virus pneumonia in four immunocompromised adults]. La Revue de medecine interne, 1999, Volume: 20, Issue:10 Topics: Antiviral Agents; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia; Respiratory Syncytial Virus Infections; Ribavirin	1999
Ribavarin in ventilated respiratory syncytial virus bronchiolitis: a randomized, placebo-controlled trial. American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:1 Topics: Antiviral Agents; Bronchiolitis, Viral; Humans; Infant; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Syncytial Virus Infections; Ribavirin	2000
Pre-emptive ribavirin for 'RSV' in BMT. Bone marrow transplantation, 2000, Volume: 26, Issue:1 Topics: Antiviral Agents; Bone Marrow Transplantation; Enzyme-Linked Immunosorbent Assay; Humans; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2000
Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral research, 2000, Volume: 47, Issue:1 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Dogs; HeLa Cells; Humans; Injections, Intraperitoneal; Lipids; Molecular Conformation; N-Acetylneuraminic Acid; Rats; Respiratory Syncytial Virus Infections; Ribavirin; Sigmodontinae; Vero Cells	2000
Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone marrow transplantation, 2001, Volume: 28, Issue:3 Topics: Aerosols; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Breast Neoplasms; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Autologous	2001
[Severe respiratory syncytial virus pneumonia in a hematopoietic stem cells transplant recipient]. Medicina clinica, 2001, Nov-03, Volume: 117, Issue:14 Topics: Adult; Antiviral Agents; Female; gamma-Globulins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin	2001
Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2001, Volume: 7 Suppl Topics: Clinical Trials as Topic; Communicable Disease Control; Community-Acquired Infections; Hematopoietic Stem Cell Transplantation; Humans; Opportunistic Infections; Paramyxoviridae Infections; Respiratory Syncytial Virus Infections; Retrospective Studies; Ribavirin; Risk Factors; Survival Rate	2001
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Bone marrow transplantation, 2001, Volume: 28, Issue:8 Topics: Administration, Oral; Adult; Anemia; Anemia, Aplastic; Antiviral Agents; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Nausea; Parainfluenza Virus 3, Human; Pilot Projects; Pneumonia, Viral; Population Surveillance; Prospective Studies; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation Conditioning; Treatment Outcome	2001
Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone marrow transplantation, 2002, Volume: 29, Issue:4 Topics: Adolescent; Adult; Aerosols; Aged; Antiviral Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Male; Middle Aged; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Transplantation, Autologous; Transplantation, Homologous	2002
Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:4 Topics: Anti-Bacterial Agents; Antiviral Agents; Bacillus; Bacterial Infections; Bronchiolitis; Child, Hospitalized; Female; Hospitals, Pediatric; Humans; Incidence; Infant; Infant, Newborn; Male; Medical Records; Pneumonia, Bacterial; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Staphylococcus; Staphylococcus epidermidis; Texas	2002